Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 30.08 | N/A |
PEG Ratio (TTM) | 0.30 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | -15,935,688.46 | N/A |
P/FCF Ratio (TTM) | -207.52 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | 800,388,981.31% | N/A |
ROE (TTM) | 160,307.09% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 283.73% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 279.03% | N/A | N/A |
Cash Flow | -16.64% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | -193.64 | N/A |
Quick Ratio (TTM) | -193.64 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | 0.29 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 17.27 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |